Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01832259
Title A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications

prostate adenocarcinoma

Therapies

Pazopanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.